Impact BioMedical Inc

Research Impact BioMedical Inc (IBO) on Bullrun: market cap USD 54.27M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIBO
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 54.27M
• Financial periodFY2025
• RevenueUSD 32.00K
• Net income-USD 11.84M
• Gross margin-1225.0%

Valuation Snapshot

latest market cap is USD 54.27M.

About Impact BioMedical Inc

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology;

Frequently asked questions

What is Impact BioMedical Inc's market cap?

Impact BioMedical Inc's market capitalization is USD 54.27M.

What does Impact BioMedical Inc do?

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.